Lutathera and ASTX727 in Neuroendocrine Tumours

Clinical trial NCT05178693 · RECRUITING

Trial details

NCT number: NCT05178693
Sponsor: Imperial College London
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2022-04-25
Primary completion: 2026-06-30
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.